Amrutanjan Health Care Limited
AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink.
What Amrutanjan files
- Others41
- Dividend/Bonus14
- Important14
- PPTs7
- Board Meeting6
- Results4
Amrutanjan Healthcare reported strong FY26: Revenue up 11% to ₹502.55 Cr, PAT up 14% to ₹57.92 Cr. Growth driven by Pain Management (+10%) and Women's Hygiene (+19%). Commissioned a new ₹150 Cr sanitary napkin plant and expanded chemist outlets. Noted exceptional impacts from lease rent of ₹9.74 Cr and new...
Amrutanjan Health Care commissioned a new ₹150 Cr sanitary napkin plant in Seetharampur, Telangana. This 1.4 lakh sq. ft. facility, their fifth, boasts 700 million annual production capacity for the Comfy brand, strengthening market position and creating jobs.
Following Mr. Raja Venkataraman's departure, Mr. Ramaswami Krishnan has assumed key committee roles at Amrutanjan Health Care. He is now Chairman of the Audit Committee and a Member of both the CSR and Risk Management Committees, marking a leadership transition.
Amrutanjan Health Care announced Q4 revenue of 149.77 Cr and FY26 revenue of 502.55 Cr. Q4 profit after tax hit 16.19 Cr, with FY26 PAT at 57.92 Cr. A final dividend of Rs 2.90 per share was declared. New independent directors were appointed, and the ESOP scheme saw an update.
Amrutanjan's board approved rolling out a revised ESOP phase, granting 200,000 shares to 44 employees. Shares vest over 5 years based on sales targets. Grant price is Rs. 502.00 (10% discount from market price). Shares will be bought via an ESOP Trust from the secondary market.